Strengths
Caplin Point has a diverse product range that includes injectables and ophthalmics, catering to various therapeutic areas.
The company boasts significant export capabilities, with 60% of its total exports coming from India, indicating a strong international presence.
A robust R&D team supports innovation, with over 900 products in the pipeline and more than 4000 product registrations.
Caplin Point's commitment to quality and affordability positions it favorably in emerging markets, particularly in Latin America and Francophone Africa.
The company has received recognition in the industry, including being listed in Forbes Asia’s '200 Best Under a Billion', enhancing its credibility.
Caplin Point's innovative business model focuses on creating new niches in existing markets, differentiating it from competitors.
The company has commenced operations at a new Oncology facility in Chennai, expanding its capabilities in a high-demand therapeutic area.
A strong brand identity built around innovation and reliability enhances customer trust and loyalty in the healthcare sector.